Marinomed Biotech AG (VIE:MARI)

Marinomed Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.91	2.59	8.18	5.8	9.21	12.02
Cash & Short-Term Investments	0.91	2.59	8.18	5.8	9.21	12.02
Cash Growth	-83.13%	-68.33%	40.90%	-36.98%	-23.40%	600.65%
Accounts Receivable	2.45	1.4	1.39	3.4	2.33	1.48
Other Receivables	-	0.98	1.73	1.41	2.85	1.68
Receivables	2.45	2.39	3.12	4.81	5.18	3.17
Inventory	0.81	1.01	1.56	1.03	0.93	0.1
Prepaid Expenses	-	1.15	1.41	1.24	0.08	0.05
Other Current Assets	-0	-	-0	0	-	-
Total Current Assets	4.18	7.14	14.27	12.88	15.4	15.34
Property, Plant & Equipment	5.75	5.94	6.2	6.43	3.07	0.67
Long-Term Investments	-	-	-	-	-	0.04
Other Intangible Assets	1.39	0.14	0.2	0.18	0.2	0.1
Long-Term Deferred Charges	-	1.38	1.61	1.83	1.86	1.52
Other Long-Term Assets	0	0.01	0.01	0.02	2.97	1.84
Total Assets	11.32	14.61	22.29	21.34	23.5	19.5
Accounts Payable	0.58	1.53	1.15	1.99	1.98	1
Accrued Expenses	-	0.71	0.82	1.54	1.18	1.39
Current Portion of Long-Term Debt	24.23	6.96	2.45	0.74	0.34	0.06
Current Portion of Leases	-	-	-	0.02	0.01	0.08
Current Unearned Revenue	1.95	0.09	0.84	1.39	0.85	0.05
Other Current Liabilities	-	0.37	0.7	0.34	1.25	1.45
Total Current Liabilities	26.76	9.65	5.96	6.01	5.61	4.03
Long-Term Debt	4.86	14.84	20.18	15.01	12.44	4.48
Long-Term Leases	-	-	-	0.04	0.02	0.03
Long-Term Unearned Revenue	0.25	0.25	0.3	0.09	0.08	0.1
Other Long-Term Liabilities	-	-	-	-0	-	-
Total Liabilities	31.87	24.75	26.44	21.15	18.14	8.64
Common Stock	1.54	1.52	1.51	1.48	1.47	1.47
Retained Earnings	-67.38	-56.55	-49.76	-43.36	-37.47	-31.45
Comprehensive Income & Other	45.3	44.89	44.09	42.07	41.35	40.85
Shareholders' Equity	-20.55	-10.14	-4.16	0.19	5.36	10.87
Total Liabilities & Equity	11.32	14.61	22.29	21.34	23.5	19.5
Total Debt	29.09	21.8	22.63	15.8	12.81	4.64
Net Cash (Debt)	-28.18	-19.21	-14.45	-10	-3.61	7.38
Net Cash Per Share	-18.57	-12.65	-9.64	-6.77	-2.45	5.20
Filing Date Shares Outstanding	1.78	1.54	1.52	1.49	1.47	1.47
Total Common Shares Outstanding	1.54	1.52	1.51	1.48	1.47	1.47
Working Capital	-22.58	-2.52	8.31	6.86	9.79	11.31
Book Value Per Share	-13.34	-6.65	-2.76	0.13	3.64	7.39
Tangible Book Value	-21.93	-10.28	-4.35	0.01	5.16	10.76
Tangible Book Value Per Share	-14.24	-6.74	-2.89	0.01	3.51	7.32
Land	-	5.91	5.91	5.89	2.65	0.36
Machinery	-	1.44	1.31	1.26	0.84	0.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.